VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 29 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,294 | +7.4% | 34,440 | 0.0% | 0.00% | – |
| Q4 2022 | $4,000 | -33.3% | 34,440 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -83.3% | 34,440 | -15.4% | 0.00% | – |
| Q2 2022 | $36,000 | -12.2% | 40,709 | +24.1% | 0.00% | – |
| Q1 2022 | $41,000 | -50.6% | 32,809 | -23.2% | 0.00% | – |
| Q4 2021 | $83,000 | +2.5% | 42,696 | +45.0% | 0.00% | – |
| Q3 2021 | $81,000 | +84.1% | 29,441 | +110.7% | 0.00% | – |
| Q2 2021 | $44,000 | -87.9% | 13,971 | -91.8% | 0.00% | -100.0% |
| Q1 2021 | $365,000 | +9.6% | 171,414 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $333,000 | +179.8% | 171,414 | 0.0% | 0.00% | – |
| Q3 2020 | $119,000 | +32.2% | 171,414 | 0.0% | 0.00% | – |
| Q2 2020 | $90,000 | +20.0% | 171,414 | 0.0% | 0.00% | – |
| Q1 2020 | $75,000 | – | 171,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,736,283 | $22,886,000 | 9.62% |
| VR Adviser, LLC | 16,047,286 | $31,292,000 | 4.28% |
| COMMODORE CAPITAL LP | 8,464,999 | $16,507,000 | 3.82% |
| Ghost Tree Capital, LLC | 2,000,000 | $3,900,000 | 1.40% |
| EPIQ PARTNERS, LLC | 1,002,350 | $1,955,000 | 1.04% |
| HighVista Strategies LLC | 577,031 | $1,125,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,024,938 | $7,849,000 | 0.86% |
| NEA Management Company, LLC | 16,302,596 | $31,790,000 | 0.64% |
| Nicholas Investment Partners, LP | 4,288,077 | $8,362,000 | 0.53% |
| Logos Global Management LP | 2,000,000 | $3,900,000 | 0.40% |